FDA and CMS: A Path for Parallel Approvals for Innovative Technologies
01 April 2012
Medical Design
Publication
Authors:
Judith A. Waltz
Medical Design
Partner Judith Waltz authored an article that appeared in Medical Design on April 1, 2012 titled "FDA and CMS: A path for parallel approvals for innovative technologies."
Click here to read the complete article.
Click here to read the complete article.
Authors
Related Services
Industry Teams
Insights
50-State Emergency Order Tracker: Roadmap to Restart - Updated June 30, 2020
01 July 2020
Coronavirus Resource Center
COVID-19 Privacy & Cybersecurity: Are you sure that PATIENT DATA is secure in the Cloud?
30 June 2020
Internet, IT & e-Discovery Blog
SEC Staff Provides Additional Disclosure Guidance Relating to the COVID-19 Pandemic
30 June 2020
Coronavirus Resource Center
Optimistic BofA “Car Wars” Report Released: The Force Will Return After the CV-19 Dark Side Lifts
30 June 2020
Dashboard Insights
Foley Represents Innovative Industrial Properties in $258.7 Million Common Stock Offering
02 July 2020
Rathburn Quoted in WWD About Enforcement of CCPA
01 July 2020
WWD
Kim, Horton Published in Managing IP About Implications of USPTO Decision on DABUS
01 July 2020
Managing IP
Utilization Management: Addressing Crucial Challenges for Health Plans (Insight Exchange Network Health Care Conference)
20-21 October 2020
Fort Lauderdale, FL
Technology’s Impact on Chronic Care: American Diabetes Association
21 July 2020
Webinar
International Dairy Foods Association (IDFA) Regulatory RoundUp Webinar
21 July 2020
Webinar
Launching into Telehealth: 2020 Northeast/Mid-Atlantic Telehealth Conference
17 July 2020
Virtual Conference